Efficacy and safety of fast-acting insulin as part versus insulin as part in children and adolescents with type 1 diabetes from japan

3Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The aim of this post-hoc subgroup analysis, which was based on data from the treat-to-target, 26-week, onset 7 trial, was to confirm the efficacy and safety of fast-acting insulin as part (faster as part) versus insulin as part (IA sp), both in combination with basal insulin degludec, in children and adolescents from Japan with type 1 diabetes (T1D). Of the onset 7 trial population (1 to <18 years; N = 777), 66 participants from Japan (65 Asian and one non-Asian) were randomized to mealtime faster as part (n = 24), post-meal faster as part (n = 19), or IA sp (n = 23). Data for the subgroup from Japan were analysed descriptively. Change from baseline in hemoglobin A1c 26 weeks after randomization was 0.23%, 0.74%, and 0.39%, for mealtime faster as part, post-meal faster as part, and IAsp respectively. Change from baseline in 1-h post-prandial glucose increment (based on 8-point self-measured blood glucose profiles) showed numerical differences in favor of mealtime faster as part versus IA sp at breakfast (–30.70 vs. –2.88 mg/dL) and over all meals (–18.21 vs. –5.55 mg/dL). There were no clinically relevant numerical differences between treatment arms in the overall rate of severe or blood glucose-confirmed hypoglycemia. At week 26, mean total insulin dose was 1.119 U/kg/day for mealtime faster as part, 1.049 U/kg/day for post meal faster as part, and 1.037 U/kg/day for IA sp. In conclusion, in children and adolescents with T1D from Japan, mealtime and post-meal faster as part with insulin degludec was efficacious in controlling glycemia without additional safety concerns versus IA sp.

Cite

CITATION STYLE

APA

Kawamura, T., Kikuchi, T., Horio, H., Rathor, N., & Ekelund, M. (2021). Efficacy and safety of fast-acting insulin as part versus insulin as part in children and adolescents with type 1 diabetes from japan. Endocrine Journal, 68(4), 409–420. https://doi.org/10.1507/endocrj.EJ20-0116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free